Sinicization of the Pediatric Respiratory Assessment Measure and test its reliability and validity
10.3760/cma.j.cn211501-20210316-00783
- VernacularTitle:儿童呼吸困难评分量表的汉化及信效度检验
- Author:
Wei ZHANG
1
;
Yuanyuan ZHANG
;
Rongrong ZHANG
;
Haiyan ZHU
;
Chaoqun ZHU
;
Yingying SUN
Author Information
1. 南京医科大学附属淮安第一医院儿科，淮安 223000
- Keywords:
Asthma, child;
Pediatric respiratory assessment measure;
Acute asthma attack;
Reliability;
Validity
- From:
Chinese Journal of Practical Nursing
2022;38(14):1110-1114
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To translate the Pediatric Respiratory Assessment Measure into Chinese, and to test its reliability and validity.Methods:According to the Brislin translation model, the English version of Pediatric Respiratory Assessment Measure was translated into Chinese, and then was back-translated and modified for cultural adaptation. From June 2019 to December 2020, convenience sampling method was used to evaluate the severity of 50 children with acute attack of bronchial asthma aged 2-14 years in the Affiliated Huaian No.1 People′s Hospital of Nanjing Medical University, in order to evaluate its reliability and validity.Results:The Cronbach α of the Chinese version of Pediatric Respiratory Assessment Measure was 0.838, the inter-rater reliability was 0.984; the average scale-content validity index was 0.97. One common factor was extracted, the cumulative variance contribution rate of superior sternal fossa depression was 61.83%. The criterion related validity between the evaluation results of doctors, nurses, respiratory therapists and the grading standard of bronchial asthma severity in the " Guidelines for the diagnosis, prevention and treatment of bronchial asthma in children ( 2016 edition)" were 0.903, 0.884 and 0.889, the ROC curve of the scale was 0.867 (95% CI 0.754-0.980). Conclusions:The Chinese version of Pediatric Respiratory Assessment Measure has good reliability and validity, which can be used to evaluate the severity of acute attack of bronchial asthma in children aged 2-14 in China, and provide a basis for further diagnosis and treatment.
